THE FIRST CELL-BASED mRNA THERAPEUTICS PLATFORM

Synthetic mRNA has reached its limits. Our cell-based mRNA design and manufacturing platform enables pure, low immunogenicity mRNA that unlocks a new era of design-based biology.